Defibrotide (DEFITELIO)

Profibrinolytic agent (oligonucleotide)

Defibrotide (DEFITELIO)

Forms and strengths
Form: TabletStrength: 200 mg/2.5 mL (80 mg/mL)
Print

Indication

  • Defibrotide is used to treat adult and pediatric patients with severe hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), occurring after hematopoietic stem-cell transplantation (HSCT).
  • Defibrotide must be prescribed and administered by specialized physicians experienced in managing complications of HSCT.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.